Description
Tirzepatide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists. It is used for the treatment of type 2 diabetes and weight loss.
Other Uses
By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, tirzepatide has been associated with significant weight loss in clinical trials. This can be particularly beneficial for individuals with type 2 diabetes, as weight management is a crucial aspect of overall diabetes care. Like other newer diabetes medications, tirzepatide has undergone cardiovascular outcomes trials. These trials assess the impact of the medication on cardiovascular events, providing valuable information on the safety and potential cardiovascular benefits of the drug.
Dosage, Concentration, Route of Administration
Dosage: Please see the unit conversion chart.
Concentration: 25mg/mL
Volume: 3mL
Route of Administration: For SQ injection only
Storage
Store under controlled refrigeration.
